Skip to Content
Morningstar

Sartorius Stedim Biotech SA DIM

Morningstar Rating
Unlock
Stock XPAR Rating as of
€205.40 −2.90 (1.39%)
View Full Chart
As of Delayed Price Open
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Sartorius Earnings: Disappointing, but Still on Track to Meet Full-Year Guidance

Jay Lee

Wide-moat Sartorius and its bioprocessing subsidiary Sartorius Stedim Biotech, or SSB, reported first-quarter earnings that were a modest disappointment to us, with revenue mildly lower than our forecast. However, we continue to see early signs of recovery in the order books, and think that the company is still on track to meet its full-year guidance. We are maintaining our fair value estimates of EUR 295 per Sartorius AG preference share and EUR 240 per SSB share, and we view the current prices as slightly cheap with a slight preference for SSB.

Read Full Report

Price vs Fair Value

View History
DIM is trading at a 13% discount.
Price
€208.70
Fair Value
€126.00
Uncertainty
High
1-Star Price
€315.00
5-Star Price
€845.00
Economic Moat
Htnqm
Capital Allocation
Ssxryvphp

Bulls Say, Bears Say

Bulls

Sartorius has limited customer concentration risk, and smaller customers account for a majority of revenue.

Bears

Sartorius risks overpaying for acquisitions to achieve somewhat arbitrary growth targets, such as its goal of EUR 4 billion of sales by 2025.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DIM is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
€208.30
Day Range
€204.80–208.30
52-Week Range
€160.55–287.80
Bid/Ask
€205.20 / €205.40
Market Cap
€19.99 Bil
Volume/Avg
10,470 / 72,645

Key Statistics

Price/Earnings (Normalized)
45.77
Price/Sales
6.52
Dividend Yield (Trailing)
0.33%
Dividend Yield (Forward)
0.33%
Total Yield
0.33%

Company Profile

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
10,662
Website
https://www.sartorius.com

Competitors

Valuation

View More
Metric
DIM
MRK
TMO
Price/Earnings (Normalized)
 45.7719.2626.68
Price/Book Value
 6.872.414.75
Price/Sales
 6.523.065.20
Price/Cash Flow
 41.2514.3025.05
Price/Earnings
DIM
MRK
TMO

Financial Strength

Metric
DIM
MRK
TMO
Quick Ratio
 0.490.791.27
Current Ratio
 1.511.421.75
Interest Coverage
 4.3811.324.94
Quick Ratio
DIM
MRK
TMO

Profitability

Metric
DIM
MRK
TMO
Return on Assets (Normalized)
 6.21%7.55%8.68%
Return on Equity (Normalized)
 15.23%13.81%18.83%
Return on Invested Capital (Normalized)
 9.77%10.19%11.14%
Return on Assets
DIM
MRK
TMO
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Instruments & Supplies Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncHvpfckhxkQhkxl$133.8 Bil
BDX
Becton Dickinson & CoYjhrxqmqSffzbx$67.6 Bil
ALC
Alcon IncNztgcvskfMgkqbw$39.1 Bil
CLPBY
Coloplast A/S ADRSdskplpkdHhss$29.7 Bil
WST
West Pharmaceutical Services IncMlvhcgqgJjsc$28.6 Bil
RMD
ResMed IncBjntzfvktPkydvwz$27.0 Bil
BAX
Baxter International IncBtvcmmfjLsxjc$20.9 Bil
COO
The Cooper Companies IncClwwwlfqJptgbs$18.2 Bil
HOLX
Hologic IncYjfkpqvfcWpdjc$17.9 Bil
TFX
Teleflex IncZxtwzLvt$9.9 Bil

Sponsor Center